Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CREARE LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-08-18 to 2025-12-17
Current total value of award: $1099954.7
Description: MEDICAL R&D DHA STTR PHASE II, PROPOSAL H2-0755, "LOW COST BLAST TEST SURROGATE"